Transcatheter heart valves technologies

Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta‐analysis

Published on 21/07/2022 | Francesco Cannata 1 et al. | ESC heart failure 2022; AOP: 10.1002/ehf2.13876 | 22 minute read

Abstract Aims Aortic stenosis (AS) and cardiac amyloidosis (CA) are typical diseases of the elderly. Up to 16% of older

Transcatheter heart valves technologies

Transcatheter tricuspid valve intervention techniques and procedural steps for the treatment of tricuspid regurgitation: a review of the literature

Published on 07/07/2022 | Kamal Matli 1 et al. | Open Heart 2022; 9(1): e002030 | 32 minute read

Abstract Severe tricuspid regurgitation (TR) is an undertreated common pathology associated with significant morbidity and mortality. Classically, surgical repair or

Transcatheter heart valves technologies

Safety and efficacy of transcatheter mitral valve repair in patients with COPD; results from real‐world cohort

Published on 16/06/2022 | Mhd Nawar AlachkarMD 1 et al. | Catheterization and Cardiovascular Interventions 2022; AOP: 10.1002/ccd.30238 | 16 minute read

Abstract Objective To evaluate the safety and efficacy of transcatheter mitral valve repair (TMVR) in patients with chronic obstructive pulmonary

Transcatheter heart valves technologies

Outcomes in Valve-in-Valve Transcatheter Aortic Valve Implantation

Published on 16/06/2022 | van Nieuwkerk et al. | The American Journal of Cardiology 2022; 172(1 June 2022): 81-9 | 0 minute read

Transcatheter heart valves technologies

Carotid ultrasound following Transcarotid Transcatheter aortic valve replacement

Published on 02/06/2022 | Panagides et al. | International Journal of Cardiology 2022; 358(1 July 2022): 12-6 | 0 minute read

Transcatheter heart valves technologies

Financial Incentives for Transcatheter Aortic Valve Implantation in Ontario, Canada: A Cost‐Utility Analysis

Published on 19/05/2022 | John K. Peel MD 1 et al. | Journal of the American Heart Association 2022; 11(8): 025085 | 31 minute read

Abstract Background Transcatheter aortic valve implantation (TAVI) is a minimally invasive therapy for patients with severe aortic stenosis, which has

Transcatheter heart valves technologies

Characterization of Cerebral Embolic Capture Using the SENTINEL Device During Transcatheter Aortic Valve Implantation in Low to Intermediate-Risk Patients: The SENTINEL-LIR Study

Published on 19/05/2022 | Kawakami et al. | Circulation: Cardiovascular Interventions 2022; 15(4): e011358 | 8 minute read

Indications for transcatheter aortic valve replacement (TAVR) have expanded to aortic stenosis patients with low- and intermediate-risk of surgery.1 Post-TAVR

Transcatheter heart valves technologies

Transcatheter aortic valve implantation in patients with rheumatic aortic stenosis

Published on 05/05/2022 | Taishi Okuno 1 et al. | Heart 2022; aop:10.1136/heartjnl-2021-320531 | 22 minute read

Abstract Background Rheumatic heart disease (RHD) accounts for the highest number of deaths from valvular heart disease globally. Yet, rheumatic

Transcatheter heart valves technologies

Wearable Smartwatch Facilitated Remote Health Management for Patients Undergoing Transcatheter Aortic Valve Replacement

Published on 21/04/2022 | Xianbao Liu MD et al. | Journal of the American Heart Association 2022; 11(7): 023219 | 19 minute read

Abstract Background In the recent decades, the development of novel digital health technologies enables doctors to monitor ECG and vital

Transcatheter heart valves technologies

Acute haemodynamic impact of transcatheter aortic valve implantation in patients with severe aortic stenosis

Published on 21/04/2022 | Francesca Graziani 1 et al. | ESC heart failure 2022; AOP: 10.1002/ehf2.13846 | 27 minute read

Abstract Aims There are limited data about the intraprocedural haemodynamic study performed immediately before and after transcatheter aortic valve implantation

This bibliographical database is provided by GNM Healthcare Group Companies USA, Inc. in full editorial independence.

The information published within the framework of this service may discuss or suggest certain therapies that have not been validated by the competent national authorities.
Service exclusively reserved for healthcare professionals.